SEC Form 4 · accession 0001209191-17-016228
Inogen Inc · INGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Byron Myers
Officer — EVP, Sales and Marketing
Period of report
Feb 28, 2017
Accepted (ET)
Mar 1, 2017 · 9:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001294133
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 28, 2017 | M | 10,000 | $16.62 | A | 45,185 | D | |
| Common Stock | Feb 28, 2017 | S | 10,000 | $70.00 | D | 35,185 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $16.62 | Feb 28, 2017 | M | 10,000 | D | — | Mar 31, 2021 | Common Stock | 10,000 | 32,791 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2016.
- F2Subject to the reporting person's continuing service, 1/48th of the total shares subject to the option shall vest every month after March 1, 2014.